HK:3880 Stock Latest News
Company AnnouncementsMedtide Calls November EGM to Approve New RSU Scheme and Governance Changes4d ago3880
Company AnnouncementsMedtide Executive Director Li Lingmei Resigns, Board Signals Continuity1M ago3880- Company AnnouncementsMedtide Inc. Outlines Board Structure and Governance Committee Roles1M ago3880
Company AnnouncementsMedtide Boosts Peptide CDMO Capacity With New Hangzhou Production Base1M ago3880
Company AnnouncementsMedtide Tightens Corporate Governance With Amendments to Articles and Internal Rules2M ago3880
Company AnnouncementsMedtide Profit Halves on Timing Shifts as Peptide CDMO Ramps Up Capacity2M ago3880
Company AnnouncementsMedtide Warns of Sharply Lower Interim Profit but Stresses Order Backlog Strength3M ago3880
Company AnnouncementsMedtide Revamps Finance Leadership and Governance Structure3M ago3880
Company AnnouncementsMedtide Unit Clears U.S. FDA Inspection for Hepcludex API, Bolstering HDV Treatment Role3M ago3880
Company AnnouncementsMedtide shareholders unanimously back board, reports at 2025 AGM4M ago3880
Company AnnouncementsMedtide to Invest USD22.7 Million in U.S. Peptide Plant Expansion4M ago3880Company AnnouncementsMedtide Sets 2025 AGM to Vote on Board, Auditors and 10% H-Share Buyback Mandate5M ago3880
Company AnnouncementsMedtide Profits Surge as Peptide Capacity and Global Certifications Expand7M ago3880
Company AnnouncementsMedtide Moves to Scrap Supervisory Committee as It Aligns Governance with New PRC Company Law7M ago3880
Company AnnouncementsMedtide Sets Board Meeting to Approve 2025 Annual Results and Consider Final Dividend7M ago3880
Company AnnouncementsMedtide Completes Full Circulation Conversion of All Shares Into H Shares7M ago3880
Company AnnouncementsMedtide Signals Sharp 2025 Profit Surge on Peptide Demand and Efficiency Gains8M ago3880
Company AnnouncementsMedtide Secures CSRC Filing for H Share Full Circulation Plan8M ago3880
